Correlation Between Achilles Therapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Cullinan Oncology LLC, you can compare the effects of market volatilities on Achilles Therapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Cullinan Oncology.
Diversification Opportunities for Achilles Therapeutics and Cullinan Oncology
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Achilles and Cullinan is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Cullinan Oncology
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.93 times more return on investment than Cullinan Oncology. However, Achilles Therapeutics PLC is 1.07 times less risky than Cullinan Oncology. It trades about 0.04 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.1 per unit of risk. If you would invest 94.00 in Achilles Therapeutics PLC on August 28, 2024 and sell it today you would earn a total of 13.00 from holding Achilles Therapeutics PLC or generate 13.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.21% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Cullinan Oncology LLC |
Achilles Therapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Cullinan Oncology
The main advantage of trading using opposite Achilles Therapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals | Cullinan Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |